Johnson & Johnson invested in OrthoSpin, an Israeli medical technology startup, according to a March 31 announcement.
Five things to know:
1. OrthoSpin raised $5 million in series B financing for its orthopedic fixation system.
2. Johnson & Johnson led the investment round with The Trendlines Group. OrthoSpin is part of the Trendlines portfolio.
3. This is Johnson & Johnson's second investment in OrthoSpin; it led a $3 million investment round in July 2018.
4. OrthoSpin will use the funding to accelerate development and clinical use of its Generation 2 smart external fixation system, which is designed to reduce the need for in-person follow-up care, as well as dependency on patient compliance.
5. OrthoSpin's Generation 1 system gained FDA clearance in September 2019. It automatically adjusts and lengthens struts in accordance with prescribed treatment regimens.
More articles on devices:
Physician group furloughs, layoffs, hours cut: economic responses to the pandemic
15 new COVID-19 cases linked to orthopedic practice in Alaska
Orthopedic surgeons among specialists called to treat COVID-19 patients in NYC